Bulk Order, Quotation, Question, E-mail to:firstname.lastname@example.org
Influenza A/California/07/2009 (A/California/07/09) Background The novel influenza A (H1N1) virus which is causing infection among humans, was first identified in the United States on 15 April 2009. On April 29th 2009, the World Health Organization (WHO) announced that the rapid global spread of a new swine origin strain of influenza A (H1N1) virus (A/California/04/2009 (H1N1), A/California/06/2009 (H1N1), A/California/07/2009 (H1N1)) detected in the previous week warranted moving the global flu pandemic alert level to phase 5. Phase 5 indicates sustained human-to-human transmission of a novel influenza strain of animal origin in one WHO region of the world, and exported cases detected in other regions. Since its outbreak, the new swine influenza H1N1 virus has infected millions of people worldwide and thousands of death. This new influenza outbreak is commonly referred to as the 2009 swine flu pandemic. Sino Biological Inc reacted quickly to the Swine Influenza Pandemic threat. Recombinant Hemagglutinin Protein from the Swine Influenza Virus Strain A/California/07/2009 (H1N1), and mouse monoclonal antibodies to the swine Influenza H1N1 Hemagglutinin protein were produced for research aim.